| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.098 | 0.02 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.02 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |